Safety and tolerability of acamprosate in alcohol-dependent individuals with bipolar disorder: An open-label pilot study

Addictive Disorders and their Treatment

Volumn 8, Issue 1, 2009, Pages 33-38

  Tolliver, Bryan K ^a   McRae, Aimee L ^a   Sonne, Susan C ^a   Brady, Kathleen T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Acamprosate; Alcohol; Bipolar disorder; Craving; Depression; Mania; Withdrawal

Indexed keywords

ACAMPROSATE; ALCOHOL; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; VALPROIC ACID;

ABDOMINAL CRAMP; ADD ON THERAPY; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BLOOD CHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NAUSEA; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

EID: 68049137868     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e31816719df     Document Type: Article

References (23)

1. Reiger DA, Farmer M, Rae D, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264:2511-2518.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
3. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807-816.
4. Tohen M, Greenfield SF, Weiss RD, et al. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv Rev Psychiatry. 1998;6:133-141. (Pubitemid 28449160)
5. Morrison JR. Bipolar affective disorder and alcoholism. Am J Psychiatry. 1974;131:1130-1133.
6. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord. 1996;37:43-49. (Pubitemid 26072815)
7. Himmelhoch JM, Mulla D, Neil JF, et al. Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatry. 1976;33:1062-1066.
8. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994;182:349-352. (Pubitemid 24227612)
9. Weiss RD, Ostacher MJ, Otto MW, et al. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005;66:730-735.
10. De Witte P, Littleton J, Parot P, et al. Neuroprotective and abstinence-promoting effects of acamprosate. Elucidating the mechanism of action. CNS Drugs. 2005;19:517-537.
11. Verheul R, Lehert P, Geerlings PJ, et al. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology. 2005; 178:167-173. (Pubitemid 40379211)
12. First MB, Spitzer RL, Gibbon M, et al. User's Guide for the Structured Clinical Interview for DSM-IV. Washington DC: American Psychiatric Press; 1997.
13. Sobell LC, Sobell MB. Timeline Followback User's Guide: a Calendar Method for Assessing Alcohol and Drug Use. Toronto: Addiction Research Foundation; 1996.
14. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996;53:225-231.
15. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429-435. (Pubitemid 9006756)
16. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. (Pubitemid 9136500)
17. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville MD: U.S. Department of Health, Education, and Welfare publication (ADM); 1976;76-338.
18. Brown ES, Beard L, Dobbs L, et al. Naltrexone in patients with bipolar disorder and alcohol dependence. Depress Anxiety. 2008;23:492-495.
19. Rubio G, Lopez-Munoz F, Alamo C. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disord. 2008;8:289-293.
20. Salloum IM, Cornelius JR, Daley DC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2005;62:37-45.
21. Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. 2004;61:450-458. (Pubitemid 38620843)
22. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr. 2005;10:809-819. (Pubitemid 41531934)
23. Saivin S, Hulot T, Chabac S, et al. Clinical pharmacokinetics of acamprosate. Clin Pharmacokinet. 1998;35:331-345.